City

Bethesda (1)

Montpellier (1)

Petach Tikva (1)

Tel Aviv (1)

Vandoeuvre Les Nancy (1)

Overall Status

Recruiting (2)

Unknown status (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Central Hospital, Nancy, France (1)

Chimerix (1)

Rabin Medical Center (1)

University Hospital, Montpellier (1)

Collaborator

Centre Hospitalier Universitaire de Besancon (1)

National Institutes of Health (NIH) (1)

Intervention

onc206 (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (2)

Observational (2)

atypical meningioma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Oncological Care for Patients With Meningioma

Recruiting

Atypical Meningioma
+5 more

Montpellier, France

Uh Montpellier

Apr 13, 2022

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting

Central Nervous System Neoplasms
+22 more

ONC206

Bethesda, Maryland

National Institutes of Health

Mar 1, 2022

Inflammatory Microenvironment in Atypical Meningiomas

Unknown status

Atypical Meningioma

Vandoeuvre Les Nancy, France

Guillaume GAUCHOTTE

Feb 16, 2021

Atypical Meningioma, Anaplastic Meningioma, Hemangiopericytoma Trial in Petach Tikva, Tel Aviv (Pembrolizumab)

Unknown status

Atypical Meningioma
+2 more

Pembrolizumab

Petach Tikva, Israel
+1 more

Apr 16, 2019